JILL CONSENTINO: Open Payments
NPI 1366509374 · RED BANK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,781 in 75 payments from 16 companies in 2025. Trend: 2023 $736 · 2024 $749 · 2025 $1,781
Food & beverage: $1,771Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $603 |
| Janssen Biotech, Inc. | 9 | $272 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $149 |
| Gilead Sciences, Inc. | 1 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
| PFIZER INC. | 5 | $92 |
| QOL Medical, LLC | 4 | $76 |
| Phathom Pharmaceuticals, Inc. | 6 | $63 |
| Novo Nordisk Inc | 3 | $55 |
| Madrigal Pharmaceuticals | 3 | $55 |
Products named: RINVOQ, TREMFYA, XIFAXAN, Epclusa, ENTYVIO, Sucraid, VOQUEZNA, VELSIPITY.
Industry payments across NJ — which companies pay providers there.
